Clinical Trial

CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or routine care (RC) plus interval blinded CGM wear.
Protocol Amendment History 1 change
notable Trial sites expanded: 18 -> 21 locations 2026-08-12
Trial Details
NCT Number NCT06601166
Lead Sponsor DexCom, Inc.
Collaborators: Jaeb Center for Health Research, Scripps Research Digital Trial Center, Precision Data Health, Inc.
Conditions Type 2 Diabetes
Enrollment 283 participants
Start Date 2024-08-15
Primary Completion 2026-05-13 (estimated)
Study Completion 2026-12-16 (estimated)
Updated on ClinicalTrials.gov 2026-08-11